Feedback / Questions
Elfabrio (pegunigalsidase alfa-iwxj) - Protalix, Chiesi
https://www.manilatimes.net/2026/01/30/tmt-newswire/globenewswire/chiesi-global-rare-diseases-and-protalix-biotherapeutics-receive-positive-chmp-opinion-for-an-additional-dosing-regimen-of-every-four-weeks-for-elfabrio-pegunigalsidase-alfa-in-the-eu/2268811
Jan 30, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next